Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions

Creative Commons License

Ince A. T., YILDIZ K., BAYSAL B., DANALIOGLU A., KOCAMAN O., TOZLU M., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.25, no.2, pp.162-169, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.5152/tjg.2014.6056
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.162-169
  • Keywords: CA 19-9, CEA, biliary obstruction, vascular endothelial growth factor receptor-3, total antioxidant capacity, PRIMARY SCLEROSING CHOLANGITIS, CARCINOEMBRYONIC ANTIGEN CEA, GROWTH-FACTOR RECEPTOR-3, ANTIOXIDANT STATUS, OXIDATIVE STRESS, BREAST-CANCER, LIPID-PEROXIDATION, TUMOR-MARKERS, DNA-DAMAGE, CHOLANGIOCARCINOMA
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background/Aims: Despite the presence of many diagnostic methods, the differential diagnosis between benign and malignant biliary obstructions is still not easy. We aimed to evaluate the role of serum/biliary carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor receptor-3(VEGFR-3), and total antioxidant capacity (TAC) tests in this differential diagnosis.